UBS Group
BLU

UBS Group’s BELLUS Health Inc. BLU Stock Holding History

UBS Group’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-58,295
Closed -$420K – 10228
2023
Q1 		$420K Buy
58,295
+2,409
+4% +$18.7K ﹤0.01% 4824
2022
Q4 		$459K Sell
55,886
-1,436
-3% -$13.4K ﹤0.01% 4777
2022
Q3 		$605K Buy
+57,322
New +$609K ﹤0.01% 4166
2022
Q1 		– Sell
-6,304
Closed -$51K – 11260
2021
Q4 		$51K Buy
6,304
+4,178
+197% +$27.7K ﹤0.01% 6885
2021
Q3 		$13K Sell
2,126
-11,824
-85% -$44.8K ﹤0.01% 7709
2021
Q2 		$43K Buy
13,950
+11,907
+583% +$45.5K ﹤0.01% 6585
2021
Q1 		$8K Sell
2,043
-2,164
-51% -$8.21K ﹤0.01% 8110
2020
Q4 		$13K Buy
4,207
+3,077
+272% +$8.34K ﹤0.01% 7302
2020
Q3 		$3K Buy
1,130
+126
+13% +$357 ﹤0.01% 7591
2020
Q2 		$10K Sell
1,004
-225
-18% -$2.28K ﹤0.01% 7041
2020
Q1 		$12K Buy
1,229
+237
+24% +$2.11K ﹤0.01% 6836
2019
Q4 		$8K Sell
992
-983
-50% -$6.72K ﹤0.01% 7411
2019
Q3 		$13K Buy
+1,975
New +$13.9K ﹤0.01% 7017

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

UBS Group's BLU Position: Q2 2023 in Review

UBS Group sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 58,295 shares — an estimated $420K sold.

UBS Group first reported a position in BLU in Q3 2019 and held it in 13 quarters. The position peaked at $605K in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • UBS Group reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • UBS Group sold 58,295 BELLUS Health Inc. shares in Q2 2023, an estimated $420K.
  • UBS Group first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 13 quarters.
  • UBS Group's BELLUS Health Inc. position peaked at $605K in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.